We are a high-complexity CAP and CLIA certified diagnostic laboratory and are in full compliance with the Health Insurance Portability and Accountability Act (HIPAA). Our lab is able to analyze various collection methods for community and individual-based testing of sexually transmitted infections, infectious disease, and other communicable diseases.
By lowering the barriers to testing, infections are identified that might otherwise have gone undetected and untreated. Creating easier access for surveillance allows public health departments the ability to work to prevent outbreaks that devastate communities. As a CLIA-certified lab, we report all reactives to local health jurisdictions.
In 2021, Molecular reported out 114,829 HIV results from patient-collected samples. Based on HRSA data from 2020, that would account for over 4.5% of the total HIV testing in America. Each month, Molecular runs over 250,000 assays on patient-collected samples. This includes testing for over 43,000 unique PrEP patients.
We are actively working to help not only eliminate barriers to testing access, but eliminate the spread of preventable diseases.
We are committed to establishing ethical standards and conducting ourselves with the utmost integrity and discretion.
We are stronger when we work collaboratively and treat employees equitably regardless of their position in the company.
We use science, technology, creativity, and persistence to solve problems.
We speak and act from a position of honesty to honor confidentiality and build trust.
We are your scientific team providing accessible and innovative laboratory solutions.
We challenge the status quo with open minds, focus and speed.
“The work you do is monumental at the early stages of Disease Control, management with a vision for elimination. The early stage implications of your activity cannot be understated.”
Bill Remak, Founder, Senior Advisor, GIANT , Global Immunization Action Network Team
Is your state equipped to reach your entire population?
84% of people when given a choice, choose at home self collect over going to a lab in person.
Seamless and Efficient Scaling of your Health Department
EMR and API integration
Patient Result Delivery
Outbound and return shipping can be tracked through our HIPAA-compliant portal which also provides live tracking and updates of the kit through the whole specimen collection process.
Our laboratory builds our test kits on demand to ship directly to the patient’s home. We can pre-build test kits to ship to your distribution center. We can even send you supplies to be used at your test site.
blandit alquim etiam erat velit scelerisque
Our in-house expert Research & Development team has been specializing in self-collect testing. Our team supports over 20 new validations for self-collect annually. Thorough testing providing better patient outcomes.
Molecular Testing Labs is committed to overcoming barriers related to geography, stigma, financial and geographical as well as increasing access to self-collect testing to reduce gaps in care.
Integrated All in One System
Manage All of Your Diagnostics
Meet All of Your Testing Needs
Our Work in the COVID-19 Pandemic
Since the onset of the COVID-19 pandemic, Molecular has worked with public officials to offer PCR testing with rapid turnaround times (TAT) to high-risk settings, including nursing homes.
Our Partnership with the Washington Department of Health
In response to a growing STI crisis in the state and to empower community-based organizations the WADOH partners can order home testing kits for patients unable to come in for testing.
Molecular Testing Labs validates Assays with the feasibility of collection in mind
Standardized collection kits have been developed that include the materials to successfully collect and return specimens. These kits are simple, cost-effective and can be used in the home